Concepedia

Chung‐Han Lee

CL

Statistics

Publications

82

Citations

9.6K

H-Index

39

Active since

1994

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

National Taiwan University

The University of Texas MD Anderson Cancer Center

Eisai (United States)

Chung‐Han Lee is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and renal cell carcinoma.

ORCID

Publications per year

1994–2025

82

Publications

82

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari et al. · Nature Genetics · 2019 · 4.4K citations · Full text

, , +14

An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma

A. Ari Hakimi, Ed Reznik, Chung‐Han Lee et al. · Cancer Cell · 2016 · 854 citations · Full text

, , +14

Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors

Matthew H. Taylor, Chung‐Han Lee, Vicky Makker et al. · Journal of Clinical Oncology · 2020 · 456 citations · Full text

, , +17

Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma

Maria I. Carlo, Semanti Mukherjee, Diana Mandelker et al. · JAMA Oncology · 2018 · 198 citations · Full text

, , +17

Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates

Chung‐Han Lee, Martin H. Voss, Maria I. Carlo et al. · Journal of Clinical Oncology · 2022 · 195 citations · Full text

, , +17

1–5 of 82